(Q44838374)

6 December 2017

title

Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice (English)

1 reference

6 December 2017

1 reference

parkinsonian syndrome

1 reference

10

M Flint Beal

1 reference

6 December 2017

Stefan Lorenzl

1

1 reference

6 December 2017

Noel Calingasan

2

1 reference

6 December 2017

Lichuan Yang

3

1 reference

6 December 2017

David S Albers

4

1 reference

6 December 2017

Shuei Shugama

5

1 reference

6 December 2017

Jason Gregorio

6

1 reference

6 December 2017

H W Krell

7

1 reference

6 December 2017

Jason Chirichigno

8

1 reference

6 December 2017

Tong Joh

9

1 reference

6 December 2017

publication date

1 January 2004

1 reference

6 December 2017

published in

NeuroMolecular Medicine

1 reference

6 December 2017

volume

5

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

119-132

1 reference

https://scigraph.springernature.com/pub.10.1385/nmm:5:2:119

6 December 2017

exact match

0 references

cites work

Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions

1 reference

12 December 2020

Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats

1 reference

12 December 2020

Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus

1 reference

12 December 2020

Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice

1 reference

12 December 2020

Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain.

1 reference

12 December 2020

The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.

1 reference

12 December 2020

Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter.

1 reference

12 December 2020

Localization of tissue inhibitor of matrix metalloproteinases in Alzheimer's disease and normal brain.

1 reference

12 December 2020

Regional and age-related expression of gelatinases in the brains of young and old rats after treatment with kainic acid

1 reference

12 December 2020

Neurodegeneration in Striatum Induced by the Mitochondrial Toxin 3-Nitropropionic Acid: Role of Matrix Metalloproteinase-9 in Early Blood-Brain Barrier Disruption?

1 reference

12 December 2020

Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein.

1 reference

12 December 2020

c-fos mRNA in mouse brain after MPTP treatment

1 reference

12 December 2020

Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase.

1 reference

12 December 2020

Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.

1 reference

12 December 2020

Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification.

1 reference

12 December 2020

Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease.

1 reference

12 December 2020

Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis.

1 reference

12 December 2020

Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion

1 reference

12 December 2020

The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1-Methyl-4-Phenyl-1,2,3,6-tetrahydropyridine to monkeys

1 reference

12 December 2020

MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo

1 reference

12 December 2020

Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration.

1 reference

12 December 2020

Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis

1 reference

12 December 2020

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

1 reference

12 December 2020

Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease.

1 reference

12 December 2020

Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia.

1 reference

12 December 2020

1 reference

12 December 2020

S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death

1 reference

12 December 2020

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

12 December 2020

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease

1 reference

12 December 2020

Quantitative zymography: detection of picogram quantities of gelatinases

1 reference

12 December 2020

Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease.

1 reference

12 December 2020

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2.

1 reference

12 December 2020

Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients

1 reference

12 December 2020

Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia

1 reference

12 December 2020

A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor.

1 reference

12 December 2020

Expression of c-Jun in dopaminergic neurons of the substantia nigra in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.

1 reference

12 December 2020

Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain.

1 reference

12 December 2020

Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease

1 reference

12 December 2020

Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

12 December 2020

The MAP Kinase Cascade Is Activated prior to the Induction of Gliosis in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Model of Dopaminergic Neurotoxicity

1 reference

12 December 2020

The role of glial reaction and inflammation in Parkinson's disease.

1 reference

12 December 2020

A consideration of neural counting methods

1 reference

12 December 2020

Identifiers

DOI

10.1385/NMM:5:2:119

1 reference

Dimensions Publication ID

6 December 2017

1030925570

0 references

Fatcat ID

release_mqv5nf2m2raxzeqzgxgcrpiqxq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mqv5nf2m2raxzeqzgxgcrpiqxq

24 November 2022

mapped directly with Wikidata item

1 reference